Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B.1.1.7) Variant in Men’s Correctional Facility, United States
Rachel A. Silverman1
, Alessandro Ceci1
, Alasdair Cohen, Meagan Helmick, Erica Short, Paige Bordwine, Michael J. Friedlander, and Carla V. Finkielstein
Author affiliations: Virginia Tech, Blacksburg, Virginia, USA (R.A. Silverman, A. Cohen, M.J. Friedlander, C.V. Finkielstein); Fralin Biomedical Research Institute, Roanoke, Virginia, USA (A. Ceci, M.J. Friedlander, C.V. Finkielstein); Virginia Department of Health, Richmond, Virginia, USA (M. Helmick, E. Short, P. Bordwine).
Figure 1. Timeline of SARS-CoV-2 vaccination rollout for incarcerated persons at a correctional facility in rural southwest Virginia included in analysis of vaccine effectiveness during a facility outbreak, April 2021.
Page created: May 21, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.